Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? ; volume:6 ; number:1 ; day:18 ; month:1 ; year:2011 ; pages:1-10 ; date:12.2011
Molecular neurodegeneration ; 6, Heft 1 (18.1.2011), 1-10, 12.2011
- Urheber
-
Greggio, Elisa
- Beteiligte Personen und Organisationen
-
Bisaglia, Marco
Civiero, Laura
Bubacco, Luigi
SpringerLink (Online service)
- DOI
-
10.1186/1750-1326-6-6
- URN
-
urn:nbn:de:1111-2016073066861
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Greggio, Elisa
- Bisaglia, Marco
- Civiero, Laura
- Bubacco, Luigi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
CLERC and centrosomal leucine-rich repeat proteins
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
The matricellular functions of small leucine-rich proteoglycans (SLRPs)
Alpha-Synuclein aggregate formation in oligodendroglia OLN-t40 cells stably transfected with alpha-Synuclein
Alpha-synuclein aggregates are phosphatase resistant
Alpha-synuclein oligomers: a new hope
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
SUMOylation modulates α-synuclein [alpha-synuclein] toxicity and fibril formation
Die Beteiligung des "small leucine-rich" Proteoglykans Osteoglycin an der Arteriogenese
A cell surface interaction network of neural leucine-rich repeat receptors
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
CLERC and centrosomal leucine-rich repeat proteins
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
The matricellular functions of small leucine-rich proteoglycans (SLRPs)
Alpha-Synuclein aggregate formation in oligodendroglia OLN-t40 cells stably transfected with alpha-Synuclein
Alpha-synuclein aggregates are phosphatase resistant
Alpha-synuclein oligomers: a new hope
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
SUMOylation modulates α-synuclein [alpha-synuclein] toxicity and fibril formation
Die Beteiligung des "small leucine-rich" Proteoglykans Osteoglycin an der Arteriogenese
A cell surface interaction network of neural leucine-rich repeat receptors
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
CLERC and centrosomal leucine-rich repeat proteins
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
The matricellular functions of small leucine-rich proteoglycans (SLRPs)
Alpha-Synuclein aggregate formation in oligodendroglia OLN-t40 cells stably transfected with alpha-Synuclein
Alpha-synuclein aggregates are phosphatase resistant
Alpha-synuclein oligomers: a new hope
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
SUMOylation modulates α-synuclein [alpha-synuclein] toxicity and fibril formation
Die Beteiligung des "small leucine-rich" Proteoglykans Osteoglycin an der Arteriogenese